Bioluminescence in Clinical and Point-of-Care Testing
Biosensors · 02.07.2025 · 15 (7) · 422
DOI: 10.3390/bios15070422 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 02.07.2025. Verfasst von Sherwin Reyes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Point-of-Care Testing, Luminescent Measurements, Biosensing Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIGMS, National Science Foundation.
Abstract (Originalsprache)
Point-of-care testing (POCT) offers a transformative approach to diagnostics by enabling rapid and accurate results at or near the site of patient care. This is especially valuable in critical care, emergency settings, and resource-limited areas. However, one major limitation of POCT remains its analytical sensitivity, particularly in detecting low concentrations of analytes. To address this, various innovations are being explored, including advanced sensors, signal amplification, and sensitive labels. Among these, bioluminescent proteins have gained attention for their high sensitivity, fast readout, minimal background interference, and simplified instrumentation. Bioluminescence—light emission from biochemical reactions—presents an ideal platform for enhancing POCT sensitivity. In parallel, metal–organic frameworks (MOFs), especially structures like ZIF-8, are emerging as valuable materials in biosensing. Their high porosity, tunable surface properties, and ability to host biomolecules make them excellent candidates for improving analyte capture and signal transduction. When integrated with bioluminescent systems, MOFs can stabilize proteins, concentrate targets, and enhance overall assay performance. This review highlights the role of bioluminescent proteins in medical diagnostics and their application in POCT platforms. We also discuss the potential synergy between MOFs and bioluminescence to overcome current sensitivity limitations. Finally, we examine existing challenges and strategies to optimize these technologies for robust, field-deployable diagnostic tools. By leveraging both the natural sensitivity of bioluminescence and the structural advantages of MOFs, next-generation POCT systems can achieve superior performance, driving forward diagnostic accessibility and patient care outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- The Dr. John T. McDonald Foundation Bionanotechnology Institute, University of Miami, Miami, FL 33136, USA.
- Nicanor Reyes Medical Foundation, Institute of Medicine, Far Eastern University, NCR, Quezon City 1119, Philippines.
- Clinical and Translational Science Institute, University of Miami, Miami, FL 33136, USA.
ORCID-Profile: Sherwin Reyes, Emre Dikici
Förderung
- NIGMS NIH HHS
- NIGMS
- National Science Foundation
- Miller School of Medicine of the University of Miami for the Lucille P. Markey Chair in Biochemistry and Molecular Biology
Zitieren
APA
Reyes, S., Rodriguez, R., Dikici, E., Daunert, S., & Deo, S. (2025). Bioluminescence in Clinical and Point-of-Care Testing. Biosensors, 15(7), 422. https://doi.org/10.3390/bios15070422
Vancouver
Reyes S, Rodriguez R, Dikici E, Daunert S, Deo S. Bioluminescence in Clinical and Point-of-Care Testing. Biosensors. 2025;15(7):422. doi:10.3390/bios15070422
BibTeX
@article{Reyes2025,
author = {Reyes, Sherwin and Rodriguez, Raymarcos and Dikici, Emre and Daunert, Sylvia and Deo, Sapna},
title = {Bioluminescence in Clinical and Point-of-Care Testing},
journal = {Biosensors},
year = {2025},
volume = {15},
number = {7},
pages = {422},
doi = {10.3390/bios15070422}
}
EUVIMED